Vision Document projects Indian textile and apparel exports to grow from $39 billion to...

India is the world’s second - largest textile producer after China. It has a large raw material base and Capable of producing a wide variety of textiles and end products. India has one of the most cost competitive textile manufacturing base for all types of products across the entire value chain. Labour cost in India is lower than most of the competing countries except Bangladesh, Ethiopia and Kenya. Although power cost is on the higher side but still cheaper than China and Cambodia. Buyers look at India as the next alternative of China as it offers big domestic market, better adherence to compliance and political stability. Government of India, National Textile Policy, vision Document projects Indian textile and apparel exports to grow from $39 billion to $300 billion by 2025.

India is estimated to have spent over $10 billion on the imports of edible...

According to United States Department of Agriculture (USDA), India’s edible oil has a market size of 20.23 million metric tonnes (MT) in volume (annual consumption) and is valued at over INR 1 trillion. (June 2015 estimates). The national per capita consumption of edible oils and fats is 14 kg per annum, which is substantially lower than the world average of 20 kg per annum. While in developed countries the figure is 35 kg per annum. India’s per capita consumption is expected to increase in future and that too substantially. India is estimated to have spent over $10 billion on the imports of edible oil, making it the third-biggest import item after crude oil and gold.

India just have 9% share of patented drugs. This shows that Indian Pharma industry...

India has 3rd largest drugs production by volume and 13th by value. It is because of generic drug production India is 3rd biggest manufacturer of drugs. It was one of the few sectors in which FDI in which more than 50% of FDI (Infact 74% of FDI) was allowed from the start. It gave boon to Indian pharma market.India just have 9% share of patented drugs. This shows that Indian Pharma industry lacks innovation in developing new drugs. Thus, India wants to succeed it has to develop and promote innovation and move up the value chain.